FDA Approves First Once-daily Single Inhaler Triple Therapy for Both Asthma, COPD Treatment
September 16, 2020

Along with COPD, fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta) is now approved for the treatment of asthma in patients aged ≥18 years.

US Adolescent E-cigarette Users at Increased Risk for COVID-19
August 17, 2020

A new survey found adolescents who have ever used e-cigarettes are 5-times more likely to receive a COVID-19 diagnosis. More results at-a-glance in our new slideshow.

Survey: Youth Vapers are Five Times More Likely to Contract COVID-19
August 12, 2020

A new survey suggests use of e-cigarettes and dual use of e-cigarettes and traditional cigarettes are significant underlying risk factors for COVID-19 among US adolescents.

ATS 2020: Novel At-home Rapid Influenza Diagnostic Test Demonstrates Good Sensitivity, Specificity
August 11, 2020

New research presented at the American Thoracic Society 2020 Virtual meeting showed the novel Theraflu Home FluTest demonstrated good sensitivity and specificity for influenza A and B viruses.

Adolescents Who Use E-cigarettes, Marijuana Have Higher Odds of Lifetime Asthma
August 10, 2020

New research presented at the ATS 2020 Virtual meeting shows adolescents who use e-cigarettes along with marijuana and/or cigarette smoking have significantly higher odds of lifetime asthma.

USPSTF: New Lung Cancer Screening Recommendations Will Double Number of Eligible Patients
July 14, 2020

The proposed recommendations will allow more women and black patients to be eligible for lung cancer screening.